Genetic variants in the ADAMTS13 and SUPT3H genes are associated with ADAMTS13 activity

被引:23
|
作者
de Vries, Paul S. [1 ]
Boender, Johan [2 ]
Sonneveld, Michelle A. H. [2 ,3 ]
Rivadeneira, Fernando [1 ,4 ]
Ikram, M. Arfan [1 ,3 ,5 ]
Rottensteiner, Hanspeter [6 ]
Hofman, Albert [1 ]
Uitterlinden, Andre G. [1 ,4 ]
Leebeek, Frank W. G. [2 ]
Franco, Oscar H. [1 ]
Dehghan, Abbas [1 ]
de Maat, Moniek P. M. [2 ]
机构
[1] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands
[2] Erasmus MC, Dept Hematol, Rotterdam, Netherlands
[3] Erasmus MC, Dept Neurol, Rotterdam, Netherlands
[4] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands
[5] Erasmus MC, Dept Radiol, Rotterdam, Netherlands
[6] Baxter Innovat GmbH, Vienna, Austria
关键词
VON-WILLEBRAND-FACTOR; THROMBOTIC THROMBOCYTOPENIC PURPURA; FACTOR-CLEAVING PROTEASE; ABO BLOOD-GROUP; SACCHAROMYCES-CEREVISIAE; MYOCARDIAL-INFARCTION; MISSENSE MUTATION; LOW-FREQUENCY; TRANSCRIPTION; GENOME;
D O I
10.1182/blood-2015-02-629865
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A disintegrin and metalloproteinase with thrombospondin motifs 13(ADAMTS13) cleaves von Willebrand factor, reducing its prothrombotic activity. The genetic determinants of ADAMTS13 activity remain unclear. We performed a genome-wide association study of ADAMTS13 activity in the Rotterdam Study, a population-based cohort study. We used imputed genotypes of common variants in a discovery sample of 3443 individuals and replication sample of 2025 individuals. We examined rare exonic variant associations in ADAMTS13 in 1609 individuals using an exome array. rs41314453 in ADAMTS13 was associated with ADAMTS13 activity in both our discovery (beta, -20.2%; P=1.3 x 10(-33)) and replication sample (P = 3.3 x 10(-34)), and explained 3.6% to 6.5% of the variance. In the combined analysis of our discovery and replication samples, there were 2 further independent associations at the ADAMTS13 locus: rs3118667 (beta, 3.0; P = 9.6 x 10(-21)) and rs139911703 (beta, -11.6; P=3.6 x 10(-8)). In addition, rs10456544 in SUPT3H was associated with a 4.2 increase in ADAMTS13 activity (P = 1.13.6 x 10(-8)). Finally, we found 3 independent associations with rare coding variants in ADAMTS13: rs148312697 (beta, -32.2%; P = 3.7 x 10(-6)), rs142572218 (beta, -46.0%; P = 3.9 x 10(-5)), and rs36222275 (beta, -13.9%; P = 2.9 x 10(-3)). In conclusion, we identified rs41314453 as the main genetic determinant of ADAMTS13 activity, and we present preliminary findings for further associations at the ADAMTS13 and SUPT3H loci.
引用
收藏
页码:3949 / 3955
页数:7
相关论文
共 50 条
  • [41] Mechanisms of ADAMTS13 regulation
    DeYoung, Veronica
    Singh, Kanwal
    Kretz, Colin A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2022, 20 (12) : 2722 - 2732
  • [42] TTP AND ADAMTS13 TESTING
    Hovinga, Johanna A. Kremer
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2014, 36 : 16 - 16
  • [43] Disappearing acts of ADAMTS13
    Voorberg, Jan
    Verbij, Fabian C.
    Fijnheer, Rob
    EBIOMEDICINE, 2015, 2 (08): : 800 - +
  • [44] ADAMTS13 in Health and Disease
    Feys, Hendrik B.
    Deckmyn, Hans
    Vanhoorelbeke, Karen
    ACTA HAEMATOLOGICA, 2009, 121 (2-3) : 183 - 185
  • [45] Genetic Modifiers of VWF Cleavage by ADAMTS13
    Zhou, Wenhua
    Tsai, Han-Mou
    BLOOD, 2008, 112 (11) : 107 - 107
  • [46] Glycans of plasma ADAMTS13
    Vanhoorelbeke, Karen
    BLOOD, 2016, 128 (21) : 2485 - +
  • [47] Special delivery for ADAMTS13
    Desch, Karl
    BLOOD, 2015, 125 (21) : 3218 - 3219
  • [48] Relapse and iTTP: beyond the ADAMTS13 activity
    Cataland, Spero R.
    BLOOD, 2024, 143 (25) : 2567 - 2568
  • [49] ADAMTS13 activity in sickle cell disease
    Schnog, John-John B.
    Hovinga, Johanna A. Kremer
    Krieg, Soraya
    Akin, Sakir
    Laemmle, Bernhard
    Brandjes, Dees P. M.
    Mac Gillavry, Melvin R.
    Muskiet, Fred D.
    Duits, Ashley J.
    AMERICAN JOURNAL OF HEMATOLOGY, 2006, 81 (07) : 492 - 498
  • [50] ADAMTS13 activity and antibodies in the antiphospholipid syndrome
    Campos, M. C.
    Rego, D.
    Morais, S.
    Pereira, M.
    Lima, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 917 - 917